Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109,421 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The efficacy and toxicity of the CHG priming regimen (low-dose cytarabine, homoharringtonine, and G-CSF) in higher risk MDS patients relapsed or refractory to decitabine.
Xiu C, Li X, Wu L, Xu F, He Q, Zhang Z, Wu D, Song L, Su J, Zhou L, Zhao Y, Tao Y, Chang C. Xiu C, et al. Among authors: zhang z. J Cancer Res Clin Oncol. 2019 Dec;145(12):3089-3097. doi: 10.1007/s00432-019-03031-w. Epub 2019 Sep 26. J Cancer Res Clin Oncol. 2019. PMID: 31559495 Clinical Trial.
Establishment and validation of an updated diagnostic FCM scoring system based on pooled immunophenotyping in CD34+ blasts and its clinical significance for myelodysplastic syndromes.
Xu F, Li X, Chang CK, Guo J, Wu LY, He Q, Zhang Z, Zhu Y, Gu SC, Shi WH, Song LX, Su JY, Zhou LY, Zhang X, Wu D. Xu F, et al. Among authors: zhang z, zhang x. PLoS One. 2014 Feb 18;9(2):e88706. doi: 10.1371/journal.pone.0088706. eCollection 2014. PLoS One. 2014. PMID: 24558415 Free PMC article.
109,421 results
You have reached the last available page of results. Please see the User Guide for more information.